Tagovameran

Approval Year

Name

Type

Language

Tagovameran

Official Name

English

RNA (recombinant 5?-(m7G-(5??5?)-ppp-Am)-capped Venezuelan equine encephalitis virus RNA-dependent RNA polymerase [551-arginine,739-leucine] codon-optimized transgene plus severe acute respiratory syndrome coronavirus 2 spike glycoprotein [682-glycine,68

Preferred Name

English

self-amplifying messenger RNA (mRNA), 5'-capped, encoding codonoptimised Venezuelan equine encephalitis virus (VEEV) RNA-dependent RNA polymerase complex (VEEV proteins nsP1, nsP2, nsP3 and nsP4) and a full-length codon-optimised pre-fusion stabilised co

Common Name

English

tagovameran [INN]

Common Name

English

Code System Code Type Description

INN

13639

Created by admin on Wed Apr 02 20:54:09 GMT 2025 , Edited by admin on Wed Apr 02 20:54:09 GMT 2025

PRIMARY

FDA UNII

BV8R57Y3YG

Created by admin on Wed Apr 02 20:54:09 GMT 2025 , Edited by admin on Wed Apr 02 20:54:09 GMT 2025

PRIMARY

CAS

2923496-70-0

Created by admin on Wed Apr 02 20:54:09 GMT 2025 , Edited by admin on Wed Apr 02 20:54:09 GMT 2025

PRIMARY

Sugar	Site Range	Site Count
D-Ribose (RNA)	1_1-1_11820	11820 / 11820

Linkage	Site Range	Site Count
Phosphate	1_2-1_11820	11819 / 11819

ACTIVE MOIETY


					BV8R57Y3YG

Tagovameran